5-150298288-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The ENST00000328668.8(ARSI):āc.636T>Cā(p.Tyr212=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.994 in 1,613,410 control chromosomes in the GnomAD database, including 796,971 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 1.0 ( 75565 hom., cov: 33)
Exomes š: 0.99 ( 721406 hom. )
Consequence
ARSI
ENST00000328668.8 synonymous
ENST00000328668.8 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.12
Genes affected
ARSI (HGNC:32521): (arylsulfatase family member I) This gene encodes a protein that belongs to a large family of sulfatases that hydrolyze sulfate esters and sulfamates. Members of this family play a role in several cellular processes, including hormone synthesis, cell signaling in development and degradation of macromolecules. The protein encoded by this gene is thought to be secreted, and to function in extracellular space. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 5-150298288-A-G is Benign according to our data. Variant chr5-150298288-A-G is described in ClinVar as [Benign]. Clinvar id is 1168278.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-1.12 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.99 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSI | NM_001012301.4 | c.636T>C | p.Tyr212= | synonymous_variant | 2/2 | ENST00000328668.8 | NP_001012301.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSI | ENST00000328668.8 | c.636T>C | p.Tyr212= | synonymous_variant | 2/2 | 1 | NM_001012301.4 | ENSP00000333395 | P1 | |
ARSI | ENST00000515301.2 | c.207T>C | p.Tyr69= | synonymous_variant | 2/2 | 4 | ENSP00000426879 | |||
ARSI | ENST00000509146.1 | c.207T>C | p.Tyr69= | synonymous_variant | 2/2 | 4 | ENSP00000420955 |
Frequencies
GnomAD3 genomes AF: 0.996 AC: 151585AN: 152166Hom.: 75506 Cov.: 33
GnomAD3 genomes
AF:
AC:
151585
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.996 AC: 246589AN: 247480Hom.: 122852 AF XY: 0.996 AC XY: 133789AN XY: 134296
GnomAD3 exomes
AF:
AC:
246589
AN:
247480
Hom.:
AF XY:
AC XY:
133789
AN XY:
134296
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.994 AC: 1451934AN: 1461126Hom.: 721406 Cov.: 93 AF XY: 0.994 AC XY: 722354AN XY: 726834
GnomAD4 exome
AF:
AC:
1451934
AN:
1461126
Hom.:
Cov.:
93
AF XY:
AC XY:
722354
AN XY:
726834
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.996 AC: 151703AN: 152284Hom.: 75565 Cov.: 33 AF XY: 0.997 AC XY: 74211AN XY: 74448
GnomAD4 genome
AF:
AC:
151703
AN:
152284
Hom.:
Cov.:
33
AF XY:
AC XY:
74211
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3474
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at